Brimonidine tartrate Gel

DRUG2 trials

Sponsors

LEO Pharma, Tarian Pharma

Conditions

EGFR Inhibitor-associated RashRosacea

Phase 2

TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis

RecruitingNCT06818058

Tarian PharmaEGFR Inhibitor-associated Rash

Start: 2025-01-20End: 2026-09-30Target: 60Updated: 2025-02-10

Unknown Phase

Preferences & Treatment Satisfaction Drivers in Rosacea Patients

CompletedNCT02602470

LEO PharmaRosacea

Start: 2015-01-08End: 2016-03-10Updated: 2020-04-01